2024-515180-56-00

A Phase 3, Multi-Center, Randomized, Single-Blind Study to Assess the Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy in Adults With Complicated Urinary Tract Infection, Acute Uncomplicated Pyelonephritis, Hospital-Acquired Bacterial Pneumonia, Ventilator-Associated Bacterial Pneumonia, and Complicated Intra-Abdominal Infection due to Carbapenem Resistant Enterobacterales (OP0595-6)

AS THE REGISTER RECORDS IT

Status and dates

Status as listed	The register records no status for this entry.
Register last updated	2025-06-17
Retrieved by this site	2026-10-03
Source	https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-515180-56-00

What this record shows

This entry describes research activity. It is not a statement about market authorisation, and it is not regulatory, legal or medical advice: a trial being listed, completed or halted says nothing about whether a substance may be sold or used anywhere. Status wording is reproduced as the register writes it and is never mapped onto a simpler vocabulary.

All records · Method

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.